Driving Excellence in Immuno-Oncology

Immuno-oncology and personalized medicine have sparked a new era in cancer research but working with a global patient base can be challenging. Together, we can shape and advance your complex trial by leveraging global, industry-leading labs, Cerba HealthCare patient databases, and our network of scientific experts spanning five continents. This intelligence — along with custom assays and on-target protocol advice — accelerates your program to market.

Nonetheless, clinical trial challenges remain. Key drivers include toxicity management, efficacy analysis, and follow-up. Parameters such as tissue distribution, tumor addiction, and surface density must be considered in predicting safety profiles.

The problem of finding proper resources to accomplish your studies compounds these hurdles. With over 35 years of experience, Cerba Research is a leader in oncology clinical trials. Our global solutions comprise a wide range of assays required at various stages of your trial.